News & Events
News articles, press releases and events Innoblative is attending
Committed to innovative surgical solutions for improved tissue coagulation and ablation, enhancing patient care.
News & Press Releases
UTMB launches feasibility study of new device used during lumpectomy procedures
The University of Texas Medical Branch (UTMB) is enrolling patients in a U.S. feasibility study evaluating the investigational SIRA radiofrequency ablation device, an innovative technology designed for use during breast‑conserving surgery. Developed by Innoblative Designs, Inc., the device is engineered
AMA Approves Category III CPT® Code for Innoblative’s SIRA® RFA Electrosurgical Device, an Adjunct for Patients Undergoing Breast Conservation Surgery
CHICAGO, March 3, 2026 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it has received Category III Current Procedural Terminology (CPT®) approval from the American Medical Association (AMA) for
Innoblative Receives U.S. IDE Approval for its Novel Electrosurgical Device for Breast Cancer Treatment
CHICAGO, April 10, 2025 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that the U.S. Food and Drug Administration has approved its Investigational Device Exemption (IDE) application, paving the
Innoblative Announces Successful First-in-Human Use of its Novel Electrosurgical Device for Breast Cancer Treatment
CHICAGO, July 16, 2024 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it has initiated its first-in-human clinical experience, successfully treating a 64-year-old patient with stage II luminal A
Innoblative Designs: Revolutionizing Post-Lumpectomy Treatment
July 27, 2023 /Medtech Outlook/ – “Our mission is to develop and commercialize novel products to intraoperatively ablate surgical margins post-excision for treating early-stage breast cancer. Developed by a team of surgeons and graduate students at Northwestern University, our SIRAT™
Innoblative Receives U.S. FDA Breakthrough Device Designation for its SIRA RFA Electrosurgical Device
Novel device is designed specifically for patients undergoing breast-conserving surgery (BCS) for breast cancer CHICAGO, April 27, 2023 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced today that it received Breakthrough
Upcoming & Past Events
Innovation Summit San Diego — MedTech Strategist
When: November 19–21, 2025 Location: The US Grant Hotel, San Diego, California Details:Experience Innovation Summit San Diego, MedTech Strategist’s premier partnering event for emerging device
Join Us at the 26th Annual Meeting of the American Society of Breast Surgeons (ASBrS) 2025
When: April 30 – May 4, 2025 Location: Bellagio Hotel in Las Vegas, NV Details: Join us at the 26th Annual Meeting of the American Society
Join Us at RESI JPM 2025
When: January 14, 2025 Location: San Francisco, CA Details: The 50th RESI Conference will be held on January 14 at the San Francisco Marriott Marquis, featuring an in-person
Join Us at the MedTech Strategist Innovation Summit
When: November 19-21, 2024 Location: US Grant Hotel in San Diego, CA Details: The MedTech Strategist Innovation Summit is an influential medical technology event that has brought
Join Us at Breastanbul 2024 For An Exclusive Symposium on Innovative Breast Cancer Treatments
When: October 11, 2024 – 16:00 – 16:30 Location: Wyndham Grand Istanbul, Hall A Symposium Title:De-escalation of Radiation for Low-Risk Breast Cancer Using Intraoperative Ablation – Is
Join Us at The 43rd Congress of the European Society of Surgical Oncology (ESSO)
When: October 2-4, 2024 Location: Antwerp, Belgium Learn more here